Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Specified Drug-use Survey of Leqvio for s.c. Injection. |
Familial Hypercholesterolaemia, Hypercholesterolaemia | Japan | NCT06275724 | |
CAR-T Long Term Follow Up (LTFU) Study |
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | Phase3 | Australia Austria Belgium Canada Denmark Finland France Germany Israel Italy Japan Norway Singapore Spain Taiwan United Kingdom United States View All |
NCT02445222 |
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis |
Multiple Sclerosis | Phase3 | France Germany Mexico Spain Ukraine United Kingdom United States View All |
NCT01892722 |
A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice |
Relapsing Forms of Multiple Sclerosis | Spain | NCT06251986 | |
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. |
Non-Small Cell Lung Carcinoma | Phase4 | India | NCT05110196 |
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus |
Systemic Lupus Erythematosus, Lupus Nephritis | Phase1, Phase2 | Australia France Germany Spain Switzerland United States View All |
NCT05798117 |
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab |
Extensive Stage Small Cell Lung Cancer | Phase1, Phase2 | France Germany Spain United Kingdom United States View All |
NCT05142696 |
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan |
Neuroendocrine Neoplasms | Phase3 | Japan | NCT06240741 |
Special Drug Use-results Surveillance of Tafinlar/Mekinist |
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor | Japan | NCT06262919 | |
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
Metastatic Neuroendocrine Prostate Cancer | Phase1 | France Spain United States |
NCT06379217 |